Active ingredient groups and their key target combinations for the treatment of UC
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Mar 13, 2025
app pub date -
Sep 7, 2023
filing date -
Sep 7, 2023
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention belongs to the field of medical technology and specifically relates to an active ingredient group for treating UC. An active ingredient group for treating UC, characterized in that it uses an active ingredient group to act on key target combination of UC, and prevents and treats UC by regulating tryptophan metabolism, glycerolphospholipid metabolism, and linoleic acid metabolism. The active ingredient group for treating UC provided in this application can effectively prevent and treat UC by regulating tryptophan metabolism, glycerolphospholipid metabolism and linoleic acid metabolism by establishing strong combination between the active ingredient group and the key target combination of UC. This application also discloses the biomarkers for the diagnosis and treatment of UC.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully